Diclazuril Protects against Maternal Gastrointestinal Syndrome and Congenital Toxoplasmosis (original) (raw)

Abstract

Background-Toxoplasmosis is a common cause of foodborne, gastrointestinal and congenital syndrome with particularly severe or unknown health consequences. There is no safe and effective preventive or therapeutic modality against congenital toxoplasmosis or to eliminate the persistent chronic infection.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (31)

  1. Dubey JP, Jones JL. Toxoplasma gondii Infection in Humans and Animals in the United States. International Journal for Parasitology. 2008; 38(11):1257-1278. http://dx.doi.org/10.1016/j.ijpara. 2008.03.007. [PubMed: 18508057]
  2. Jones JL, Kruszon-Moran D, Wilson M, Mcquillan G, Navin T, Mcauley JB. Toxoplasma gondii Infection in the United States: Seroprevalence and Risk Factors. American Journal of Epidemiology. 2001; 154(4):357-365. http://dx.doi.org/10.1093/aje/154.4.357\. [PubMed: 11495859]
  3. Buxton D, Thomson K, Maley S, Wright S, Bos HJ. Vaccination of Sheep with a Live Incomplete Strain (S48) of Toxoplasma gondii and their Immunity to Challenge When Pregnant. Veterinary Record. 1991; 129(5):89-93. http://dx.doi.org/10.1136/vr.129.5.89\. [PubMed: 1926725]
  4. Wolf A, Cowen D, Paige B. Human Toxoplasmosis: Occurrence in Infants as an Encephalomyelitis Verification by Transmission to Animals. Science. 1939; 89(2306):226-227. http://dx.doi.org/ 10.1126/science.89.2306.226. [PubMed: 17737029]
  5. Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R. Congenital Toxoplasmosis: A Review. Obstetrical & Gynecological Survey. 2001; 56(5):296-305. http://dx.doi.org/ 10.1097/00006254-200105000-00025. [PubMed: 11333376]
  6. Wong SY, Remington JS. Toxoplasmosis in Pregnancy. Clinical Infectious Diseases. 1994; 18(6): 853-861. http://dx.doi.org/10.1093/clinids/18.6.853\. [PubMed: 8086543]
  7. Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Gilbert RE. European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Prenatal Treatment for Serious Neurological Sequelae of Congenital Toxoplasmosis: An Observational Prospective Cohort Study. PLOS Medicine. 2010; 7(10):1-10. http://dx.doi.org/ 10.1371/journal.pmed.1000351.
  8. Berrébi A, Assouline C, Bessières MH, Lathière M, Cassaing S, Minville V, Ayoubi JM. Long- Term Outcome of Children with Congenital Toxoplasmosis. American Journal of Obstetrics & Gynecology. 2010; 203(6):552-558. http://dx.doi.org/10.1016/j.ajog.2010.06.002\. [PubMed: 20633868]
  9. Habib FA. Post-Treatment Assessment of Acute Toxoplasma Infection during Pregnancy. Journal of Obstetrics & Gynaecology. 2008; 28(6):593-595. http://dx.doi.org/10.1080/01443610802344332\. [PubMed: 19003652]
  10. Julliac B, Théophile BH, Begorre M, Richez B, Haramburu F. Side effects of Spiramycin Masquerading as Local Anesthetic Toxicity during Labor Epidural Analgesia. International Journal of Obstetric Anesthesia. 2010; 19(3):331-332. http://dx.doi.org/10.1016/j.ijoa. 2010.03.002. [PubMed: 20627689]
  11. Oz HS, Tobin T. Atovaquone Ameliorates Gastrointestinal Toxoplasmosis Complications in a Pregnancy model. Medical Science Monitor. 2012; 18(9):BR337-BR345. http://dx.doi.org/ 10.12659/MSM.883342. [PubMed: 22936182]
  12. Granstrom, DE.; Tobin, T. Treatment of EPM Formulations and Methods to Treat and Prevent Equine Protozoal Myeloencephalitis. US Patent No. 5,883,095. 1999.
  13. Assis RCL, Luns FD, Beletti ME, Assis RL, Nasser NM, Faria ESM, Cury MC. Histomorphometry and Macroscopic Intestinal Lesions in Broilers Infected with Eimeria Acervulina. Veterinary Parasitology. 2010; 168(3-4):185-189. http://dx.doi.org/10.1016/j.vetpar. 2009.11.017. [PubMed: 20080348]
  14. Hackstein JH, Mackenstedt U, Mehlhorn H, Meijerink JP, Schubert H, Leunissen JA. Parasitic Apicomplexans Harbor a Chlorophyll a-D1 Complex, the Potential Target for Therapeutic Triazines. Parasitology Research. 1995; 81(3):207-216. [PubMed: 7770426]
  15. Ajzenberg D, Cogne N, Paris L, Bessieres MH, Thulliez P, Filisetti P. Genotype of 86 Toxoplasma gondii Isolates Associated with Human Congenital Toxoplasmosis, and Correlation with Clinical Findings. The Journal of Infectious Diseases. 2002; 186(5):684-689. http://dx.doi.org/ 10.1086/342663. [PubMed: 12195356]
  16. Howe DK, Honore S, Derouin F, Sibley LD. Determination of Genotypes of Toxoplasma gondii Strains Isolated from Patients with Toxoplasmosis. Journal of Clinical Microbiology. 1997; 35(6): 1411-1414. [PubMed: 9163454]
  17. Oz HS, Ebersole J, de Villiers WJ. The Macrophage Pattern Recognition Scavenger Receptors SR- A and CD36 Protect against Microbial Induced Pregnancy Loss. Inflammation Research. 2011; 60(1):93-97. http://dx.doi.org/10.1007/s00011-010-0241-1\. [PubMed: 20711846]
  18. Oz HS, Chen T, de Villiers TWJ, McClain C. Glutathione Enhancing Agents Protect against Steatohepatitis in a Model. Journal of Biochemical and Molecular Toxicology. 2006; 20(1):39-47. http://dx.doi.org/10.1002/jbt.20109\. [PubMed: 16498637]
  19. Oz HS, Chen T, Nagasawa H. Comparative Efficacies of Two Cysteine Prodrugs and a Glutathione Delivery Agent in a Colitis Model. Translational Research. 2007; 150(2):122-129. http:// dx.doi.org/10.1016/j.trsl.2006.12.010. [PubMed: 17656332]
  20. Oz HS, Chen T, de Villiers WJS. Green Tea Polyphenols and Sulfasalazine have Parallel Anti- inflammatory Properties in Colitis Models. Frontiers in Immunology. 2013; 4:1-10. Article. 132. [PubMed: 23355837]
  21. Westlund KN, Zhang L, Ma F, Oz HS. Chronic Inflammation and Pain in a Tumor Necrosis Factor Receptor (TNFR) (p55/p75-/-) Dual Deficient Murine Model. Translational Research. 2012; 160(1):84-94. http://dx.doi.org/10.1016/j.trsl.2011.10.003\. [PubMed: 22687964]
  22. Thiébaut R, Leproust S, Chêne G, Gilbert R. Effectiveness of Prenatal Treatment for Congenital Toxoplasmosis: A Meta-Analysis of Individual Patients' Data SYROCOT (Systematic Review on Congenital Toxoplasmosis) Study Group. The Lancet. 2007; 369(9556):115-122. http:// dx.doi.org/10.1016/S0140-6736(07)60072-5.
  23. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV. Food- Related Illness and Death in the United States. Emerging Infectious Diseases. 1999; 5(5):606-625.
  24. Robertson LJ, van der Giessen JW, Batz MB, Kojima M, Cahill S. Have Foodborne Parasites Finally Become a Global Concern? Trends in Parasitology. 2013; 29(3):101-103. http://dx.doi.org/ 10.1016/j.pt.2012.12.004. [PubMed: 23375923]
  25. Bessières MH, Berrebi A, Cassaing S, Fillaux J, Cambus JP, Berry A, Assouline C, Ayoubi JM, Magnaval JF. Diagnosis of Congenital Toxoplasmosis: Prenatal and Neonatal Evaluation of Methods Used in Toulouse University Hospital and Incidence of Congenital Toxoplasmosis. Memórias do Instituto Oswaldo Cruz. 2009; 104(2):389-392. http://dx.doi.org/10.1590/ S0074-02762009000200038. [PubMed: 19430670]
  26. Dirikolu L, Lehner AF, Nattrass C, Bentz BG, Woods WE, Carter WG, Karpiesiuk W, Jacobs J, Boyles J, Harkins JD, Granstrom DE, Tobin T. Diclazuril in the Horse: Its Identification and Detection and Preliminary Pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics. 1999; 22(6):374-379. http://dx.doi.org/10.1046/j.1365-2885.1999.00232.x. [PubMed: 10651466]
  27. Dirikolu L, Foreman JH, Tobin T. Current Therapeutic Approaches to Equine Protozoal Myeloencephalitis. Journal of the American Veterinary Medical Association. 2013; 242(4):482- 491. http://dx.doi.org/10.2460/javma.242.4.482\. [PubMed: 23363280]
  28. Lindsay DS, Dubey JP. Determination of the Activity of Diclazuril against Sarcocystis Neurona and Sarcocystis Falcatula in Cell Cultures. Journal of Parasitology. 2000; 86(1):164-166. [PubMed: 10701584]
  29. Lindsay DS, Blagburn BL. Activity of Diclazuril against Toxoplasma gondii in Cultured Cells and Mice. American Journal of Veterinary Research. 1994; 55(4):530-533. [PubMed: 8017699]
  30. Work TM, Massey G, Rideout BA, Gardiner CH, Ledig DB, Kwok OCH, Dubey JP. Fatal Toxoplasmosis in Fee-Ranging Endangered 'ALALA' from Hawaii. Journal of wildlife diseases. 2000; 36(2):205-212. http://dx.doi.org/10.7589/0090-3558-36.2.205\. [PubMed: 10813600]
  31. Zhou BH, Wang HW, Zhao ZS, Liu M, Yan WC, Zhao J, Zhang Z, Xue FQ. A Novel Serine/ Threonine Protein Phosphatase Type 5 from Second-Generation Merozoite of Eimeria Tenella Is Associated with Diclazuril-Induced Apoptosis. Parasitology Research. 2013; 112(4):1771-1780. http://dx.doi.org/10.1007/s00436-013-3336-0\. [PubMed: 23417098]